Close
Back to AIM Stock Lookup

AIM ImmunoTech (AIM) – Momentum Movers

Apr 11, 2022 07:12 AM AIM ImmunoTech (AIM) Announces Positive Data from Phase 2a Study Evaluating Ampligen as a Component of a Chemokine Modulatory Regimen for the Treatment of Colorectal Cancer Metastatic to the Liver
Jul 6, 2020 09:16 AM AIM ImmunoTech (AIM) Enters Material Transfer and Research Agreement with Japan's National Institute of Infectious Diseases and Shionogi to Test COVID-19 Therepy
Mar 9, 2020 06:48 AM

Back to AIM Stock Lookup